Abstract Background Feline leukemia virus (FeLV) induces degenerative, proliferative and malignant hematologic disorders in its natural host, the domestic cat. FeLV-945 is a viral variant identified as predominant in a cohort of naturally infected animals. FeLV-945 contains a unique sequence motif in the long terminal repeat (LTR) comprised of a single copy of transcriptional enhancer followed by a 21-bp sequence triplicated in tandem. The LTR is precisely conserved among independent cases of multicentric lymphoma, myeloproliferative disease and anemia in animals from the cohort. The 21-bp triplication was previously shown to act as a transcriptional enhancer preferentially in hematopoietic cells and to confer a replicative advantage. The o...
AbstractThe U3-LTR region of leukemia viruses transactivates cancer-related signaling pathways throu...
Nuclear protein binding sites in the long terminal repeat (LTR) of feline immunodeficiency virus (FI...
AbstractWe investigated effects of site-specific mutation of the putative C/EBP binding site in the ...
Abstract Background The development of anaemia in feline leukaemia virus (FeLV)-infected cats is ass...
Domestic cats infected with the horizontally transmitted feline leukemia virus subgroup A (FeLV-A) o...
Retroviral infection requires an initial interaction between the host cell and the virion. This inte...
FeLV is a member of the retrovirus family characterized by transcribing RNA into DNA using the enzym...
AbstractThe U3 region of the LTR of oncogenic Moloney murine leukemia virus (Mo-MuLV) and feline leu...
A recombinant feline leukemia virus (FeLV) proviral clone (T17T-22) with a long terminal repeat (LTR...
Certain isolates of the oncoretrovirus feline leukemia virus (FeLV) are strongly cytopathic for hemo...
AbstractTo determine what genetic changes are selected in the enhancer sequences of the feline leuke...
Feline leukemia viruses (FeLVs) are pathogenic retroviruses of the domestic cat. FeLV transmission a...
The feline leukemia virus (FeLV) causes degenerative and proliferative hemolymphatic diseases in dom...
AbstractFeline leukemia virus (FeLV) subgroup B arises de novo through recombination between the env...
AbstractDuring feline leukemia virus (FeLV) infection in the domestic cat, viruses with a novel enve...
AbstractThe U3-LTR region of leukemia viruses transactivates cancer-related signaling pathways throu...
Nuclear protein binding sites in the long terminal repeat (LTR) of feline immunodeficiency virus (FI...
AbstractWe investigated effects of site-specific mutation of the putative C/EBP binding site in the ...
Abstract Background The development of anaemia in feline leukaemia virus (FeLV)-infected cats is ass...
Domestic cats infected with the horizontally transmitted feline leukemia virus subgroup A (FeLV-A) o...
Retroviral infection requires an initial interaction between the host cell and the virion. This inte...
FeLV is a member of the retrovirus family characterized by transcribing RNA into DNA using the enzym...
AbstractThe U3 region of the LTR of oncogenic Moloney murine leukemia virus (Mo-MuLV) and feline leu...
A recombinant feline leukemia virus (FeLV) proviral clone (T17T-22) with a long terminal repeat (LTR...
Certain isolates of the oncoretrovirus feline leukemia virus (FeLV) are strongly cytopathic for hemo...
AbstractTo determine what genetic changes are selected in the enhancer sequences of the feline leuke...
Feline leukemia viruses (FeLVs) are pathogenic retroviruses of the domestic cat. FeLV transmission a...
The feline leukemia virus (FeLV) causes degenerative and proliferative hemolymphatic diseases in dom...
AbstractFeline leukemia virus (FeLV) subgroup B arises de novo through recombination between the env...
AbstractDuring feline leukemia virus (FeLV) infection in the domestic cat, viruses with a novel enve...
AbstractThe U3-LTR region of leukemia viruses transactivates cancer-related signaling pathways throu...
Nuclear protein binding sites in the long terminal repeat (LTR) of feline immunodeficiency virus (FI...
AbstractWe investigated effects of site-specific mutation of the putative C/EBP binding site in the ...